Well it surely seems as though Medify is assuming there was intent behind the suspension, impossible to really know. But why, the price had settled around 20c-30c for months, and honestly, from what it was(4$-6$), to me there's no difference if it 30c or 10c, it's not worth selling. I think it was a clerical error (pathetic as it is), as these people are juggling multiple businesses, and with the current economic climate it was put on a to do list, that was just shuffled around until it was too late. Anyway, I can only assume that's what happened, so hopefully that could be a question at the next annual meeting. We'll see if it comes back on the market next week, it will be interesting to see if the current level holds. GL
PO3 Price at posting:
22.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.